A sticky, protein-rich gel created by Johns Hopkins researchers appears to help stem cells stay on or in rat hearts and restore their metabolism after transplantation, improving cardiac function after simulated heart attacks, according to results of a new study.

September 29, 2015 — A new report from the American Heart Association (AHA) projects that the number of Americans diagnosed with heart failure (HF) will increase nearly 40 percent within 15 years, and the associated costs will nearly double. With these numbers in mind, the AHA announced the launch of the national Rise Above Heart Failure initiative.  

The Innovation Institute announced that Boston Scientific has signed an agreement to become the founding medical device sponsor of the institute’s Innovation Lab in Newport Beach, California.

New 12-month clinical trial outcomes assessing the safety and performance of the Boston Scientific Eluvia drug-eluting vascular stent system reflect a primary patency rate of more than 96 percent.

Researchers have discovered how to predict some cardiac arrhythmias several steps before they even occur. It’s a finding that could lead to an improved cardiac device, with equipment designed to detect when arrhythmias are about to occur and then act to prevent them.

The Icahn School of Medicine at Mount Sinai has launched the international TWILIGHT clinical trial to test the safety and effectiveness of treating coronary stent patients with ticagrelor alone instead of combining it with aspirin, which is the current standard of care.

Medisafe, an mHealth platform for medication management, announced the results of its blood pressure study, which showed app users with stage 1 or stage 2 hypertension decreased their systolic blood pressure by 17.7 and 25.3 mmHg, respectively, within 30 days.

At the 2015 IEEE High Performance Extreme Computing Conference (HPEC ‘15), ContextVision presented new results of research conducted with Texas Instruments (TI) and High Performance Consulting. The study outlines the achievement of low latency, reduced memory footprint and low power consumption through data streaming, specifically as a modification to portable ultrasound imaging devices.

The American College of Cardiology (ACC) launched two new clinical registry programs in August to track real-world outcomes for the treatment and stroke prevention of patients with atrial fibrillation.

SHAPE, The Society for Heart Attack Prevention and Eradication, met with an international contingent of leading cardiologists and researchers to mark a decade of progress and determine the way forward. The SHAPE Trial Advisory Meeting took place Aug. 21-23, 2015, in Los Angeles.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now